Suchergebnisse - "1354-3784" OR "1744-7658"

PubPharm (8.583)

3561

Tumor heterogeneity and strategies to overcome kinase inhibitor resistance in cancer : lessons from melanoma

enthalten in: Expert opinion on investigational drugs | 2011

von Rebecca, V. | Smalley, K.

3562

Novel mitogen-activated protein kinase kinase inhibitors

enthalten in: Expert opinion on investigational drugs | 2011

von Chapman, M. | Miner, J.

3563

Mechanisms of drug resistance in kinases

enthalten in: Expert opinion on investigational drugs | 2011

von Barouch-Bentov, R. | Sauer, K.

3564

Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses

enthalten in: Expert opinion on investigational drugs | 2011

von Narayanan, A. | Bailey, C. | Kashanchi, F. | +1

3565

Targetable molecular pathways in classical Hodgkin's lymphoma

enthalten in: Expert opinion on investigational drugs | 2011

von Adams, H. | Obermann, E. | Dirnhofer, S. | +1

3566

Sex hormones and lipoprotein(a) concentration

enthalten in: Expert opinion on investigational drugs | 2011

von Gaeta, G. | Lanero, S. | Barra, S. | +4

3567

The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patients

enthalten in: Expert opinion on investigational drugs | 2011

von Kruser, T. | Traynor, A. | Wheeler, D.

3568

Lenalidomide in the treatment of chronic lymphocytic leukemia

enthalten in: Expert opinion on investigational drugs | 2011

von Gentile, M. | Recchia, A. | Vigna, E. | +13

3569

Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases

enthalten in: Expert opinion on investigational drugs | 2011

von Suzuki, J. | Ogawa, M. | Muto, S. | +4

3570

Mipomersen, an antisense apolipoprotein B synthesis inhibitor

enthalten in: Expert opinion on investigational drugs | 2011

von Bell, D. | Hooper, A. | Burnett, J.